Quest Diagnostics (DGX)
undefined
undefined%
At close: undefined
151.92
-0.03%
After-hours Jan 03, 2025, 04:10 PM EST

Company Description

Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally.

The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services.

It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to patients, clinicians, hospitals, independent delivery networks, health plans, employers, direct contract entities, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile paramedics, nurses, and other health and wellness professionals.

The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians robust information technology solutions.

Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.

Quest Diagnostics
Quest Diagnostics logo
Country United States
IPO Date Dec 17, 1996
Industry Medical - Diagnostics & Research
Sector Healthcare
Employees 50,000
CEO James E. Davis

Contact Details

Address:
500 Plaza Drive
Secaucus, New Jersey
United States
Website https://www.questdiagnostics.com

Stock Details

Ticker Symbol DGX
Exchange NYSE
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001022079
CUSIP Number 74834L100
ISIN Number US74834L1008
Employer ID 16-1387862
SIC Code 8071

Key Executives

Name Position
James E. Davis Chairman, Chief Executive Officer & President
Sam A. Samad Executive Vice President & Chief Financial Officer
Catherine T. Doherty Executive Vice President of Regional Businesses
Garry Clark Senior Vice President and Chief Marketing & Communications Officer
Karthik Kuppusamy Ph.D. Senior Vice President of Clinical Solutions
Kristin Lee Wallace Esq. Senior Vice President & Chief Compliance Officer
Michael E. Prevoznik J.D. Senior Vice President & General Counsel
Michael J. Deppe Senior Vice President, Corporate Controller & Chief Accounting Officer
Murali Balakumar Senior Vice President, Chief Information & Digital Officer
Shawn C. Bevec Vice President of Investor Relations

Latest SEC Filings

Date Type Title
Dec 02, 2024 4 Filing
Dec 02, 2024 4 Filing
Nov 07, 2024 4 Filing
Oct 30, 2024 4 Filing
Oct 25, 2024 4 Filing
Oct 25, 2024 4 Filing
Oct 25, 2024 4 Filing
Oct 25, 2024 4 Filing
Oct 25, 2024 4 Filing
Oct 23, 2024 10-Q Quarterly Report